Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL).

Zhang W, Fan Y, Li M, Yang L, Zhang Z, Liu L

DOI: 10.1155/2021/4894022
Published: 2021
Container: Disease markers
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1155/2021/4894022,
  title = {Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL).},
  author = {Zhang W and Fan Y and Li M and Yang L and Zhang Z and Liu L},
  year = {2021},
  journal = {Disease markers},
  doi = {10.1155/2021/4894022},
  url = {https://doi.org/10.1155/2021/4894022}
}

RIS

TY  - JOUR
TI  - Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL).
AU  - Zhang W
AU  - Fan Y
AU  - Li M
AU  - Yang L
AU  - Zhang Z
AU  - Liu L
PY  - 2021
JO  - Disease markers
DO  - 10.1155/2021/4894022
UR  - https://doi.org/10.1155/2021/4894022
ER  -

APA

W, Z., Y, F., M, L., L, Y., Z, Z., & L, L. (2021). Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL).. Disease markers. https://doi.org/10.1155/2021/4894022

Source records

pubmed · retrieved 2026-09-25T09:05:25.486Z